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Summary 10 
UPF1 is an RNA helicase that is required for efficient nonsense-mediated mRNA 11 
decay (NMD) in eukaryotes, and the predominant view is that UPF1 mainly operates 12 
on the 3’UTRs of mRNAs that are directed for NMD in the cytoplasm. Here we offer 13 
evidence, obtained from Drosophila, that UPF1 constantly moves between the nucleus 14 
and cytoplasm by a mechanism that requires its RNA helicase activity. UPF1 is 15 
associated, genome-wide, with nascent RNAs at most of the active Pol II transcription 16 
sites and at some Pol III-transcribed genes, as demonstrated microscopically on the 17 
polytene chromosomes of salivary glands and by ChIP-seq analysis in S2 cells. Intron 18 
recognition seems to interfere with association and translocation of UPF1 on nascent 19 
pre-mRNAs, and cells depleted of UPF1 show defects in the release of mRNAs from 20 
transcription sites and mRNA export from the nucleus.  21 
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Introduction 28 
UPF1 (UP-Frameshift-1) is a universally conserved eukaryotic protein that was first 29 
identified in a Saccharomyces cerevisiae genetic screen for mutations that enhance 30 
up-frameshift tRNA suppression (Culbertson et al., 1980; Leeds et al., 1992), and 31 
gained other names – including NAM7 (S. cerevisiae) and SMG2 (Caenorhabditis 32 
elegans) – from other genetic screens (Altamura et al., 1992; Hodgkin et al., 1989; 33 
Pulak and Anderson, 1993 ). Cells that lack active UPF1 accumulate mRNAs with 34 
nonsense, frameshift or other mutant alleles that introduce a premature translation 35 
termination codon (PTC) (Leeds et al., 1991; Pulak and Anderson, 1993).  36 
These observations are generally interpreted as evidence that UPF1 and related 37 
proteins are primarily required for nonsense-mediated mRNA decay (NMD), a 38 
conserved eukaryotic mRNA surveillance mechanism that detects and destroys 39 
mRNAs on which translation terminates prematurely (Fatscher et al., 2015; He and 40 
Jacobson, 2015; Karousis et al., 2016; Kurosaki and Maquat, 2016). NMD is mainly 41 
regarded as a quality control mechanism that prevents cells from wastefully making 42 
truncated (and potentially toxic) proteins and that regulates the selective expression of 43 
specific mRNA isoforms during cell homeostasis and differentiation (Goetz and 44 
Wilkinson, 2017; Lykke-Andersen and Jensen, 2015).  45 
The exact role of UPF1 in NMD is uncertain though. Standard models postulate that 46 
UPF1 monitors translation termination on ribosomes by interacting with a peptide 47 
release factor (eRF1 or eRF3). However, recent reports on mammalian translation 48 
systems have suggested, in contrast to earlier reports on other organisms (Czaplinski 49 
et al., 1998; Ivanov et al., 2008; Kashima et al., 2006; Keeling et al., 2004; Singh et 50 
al., 2008; Wang et al., 2001), that UPF1 does not bind to either of these. They 51 
suggested, instead, that UPF3B may contact release factors, slow the termination of 52 
translation and facilitate post-termination release of ribosomes – and so fulfil the 53 
termination monitoring role that has been assigned to UPF1 (Neu-Yilik et al., 2017).  54 
UPF1 is an ATP-driven helicase that unwinds RNA secondary structures and so can 55 
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displace RNA-bound proteins (Bhattacharya et al., 2000; Chakrabarti et al., 2011; 56 
Czaplinski et al., 1995; Fiorini et al., 2015; Franks et al., 2010). UPF1 is 57 
predominantly associated with 3’UTRs of cytoplasmic mRNAs which indicates that it 58 
might be selectively recruited to or activated on NMD targets with abnormally long 59 
3’UTRs (Karousis et al., 2016; Kurosaki and Maquat, 2016). However, UPF1 appears 60 
to bind mRNAs fairly indiscriminately, regardless of the position of the stop codon or 61 
the PTC and whether or not the mRNA possess NMD-inducing features such as an 62 
abnormally long 3’UTR or an exon junction downstream of the stop codon (Hogg and 63 
Goff, 2010; Hurt et al., 2013; Zund et al., 2013). UPF1 helicase activity is required for 64 
NMD, but how it helps to target particular transcripts for NMD remains unclear. It has 65 
also been questioned whether cells do possess any such mechanism to discriminate 66 
between PTCs and normal stop codons (Brogna et al., 2016).  67 
UPF1 is most abundant in the cytoplasm where its roles discussed above depend on 68 
ribosomal translation and occur on cytoplasmic mRNAs. A fraction of UPF1 was 69 
expected in the nucleus though, as the protein traffics in and out of the nucleus in 70 
mammalian cells (Ajamian et al., 2015; Mendell et al., 2002). Some studies have 71 
concluded that within the nucleus UPF1 plays a distinct and direct role in DNA 72 
replication, which would be unrelated to gene expression (Azzalin and Lingner, 2006; 73 
Azzalin et al., 2007; Carastro et al., 2002; Chawla et al., 2011). The negative effects 74 
that depletion of UPF1 has on DNA replication and cell division could be an indirect 75 
consequence of NMD suppression though, by altering the expression of genes 76 
required in such processes (Varsally and Brogna, 2012). Moreover, there is evidence 77 
that nuclear UPF1 might contribute directly to RNA processing, at least in specific 78 
instances, and is required for nuclear export of HIV-1 genomic RNA in HeLa cells 79 
(Ajamian et al., 2015; de Turris et al., 2011; Flury et al., 2014; Varsally and Brogna, 80 
2012). Additionally, CLIP data indicates direct binding of UPF1 with the abundant 81 
nuclear-localised metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) 82 
in mammalian cells (Zund et al., 2013). 83 
In the present study, we show direct evidence that UPF1 is globally involved in 84 
 4 
nuclear processing of mRNAs in Drosophila. First, we demonstrate that UPF1 is a 85 
highly mobile protein that constantly shuttles between the nucleus and cytoplasm, and 86 
its distribution in the cell, with more in the cytoplasm than the nucleus, depends on its 87 
RNA binding properties and approximately reflects that of mRNA. UPF1 associates 88 
with nascent transcripts on chromosomes – mostly with Pol II transcripts, but also 89 
with some Pol III-transcribed genes. Relatively more of the transcript-associated 90 
UPF1 is bound with exons than with introns, suggesting that intron recognition might 91 
act as a roadblock to the 5’-to-3’ transit of UPF1 along the pre-mRNA. Most 92 
strikingly, UPF1 is needed for the efficient release of polyadenylated mRNAs from 93 
most chromosomal transcription sites and for their export from the nuclei. These 94 
observations indicate that UPF1 starts scanning pre-mRNA transcripts whilst they are 95 
still being assembled into ribonucleoprotein (RNP) complexes on chromosomes and 96 
suggest that UPF1 fulfils previously unrecognised role(s) in facilitating nuclear 97 
processes of gene expression and mRNA export. The broad and dynamic association 98 
of UPF1 with mRNAs redefines it from being primarily an NMD-inducing factor to 99 
being a global player in mRNA processing in the nucleus as well as in the cytoplasm, 100 
and might also explain why none of the prevailing models satisfactorily explain how 101 
UPF1 could target specific transcripts to NMD. 102 
 103 
 104 
105 
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Results 106 
Drosophila anti-UPF1 antibodies 107 
To explore the functions of UPF1, we generated three monoclonal anti-peptide 108 
antibodies that target regions of Drosophila UPF1 outside the RNA helicase domain: 109 
one epitope in the N-terminal flanking regions (antibody 1C13 against Pep2), and two 110 
near the C-terminus (Ab 7D17 vs. Pep11; and Ab 7B12 vs. Pep12) (see Figure 1-figure 111 
supplement 1A and 1B, and Supplementary file 1). Following purification from 112 
hybridoma supernatants, each antibody detected UPF1 as a single band by Western 113 
blotting of Drosophila S2 cell extracts, with minimal cross-reactivity with other 114 
proteins (Figure 1A, Figure 1-figure supplement 1C and 1D). The antibodies also 115 
detected a second, larger band of the expected molecular weight in extracts from S2 116 
cells that over-express UPF1-GFP. Unless otherwise indicated, antibody 7B12 was 117 
used in the experiments described below. As expected, UPF1-RNAi specifically 118 
reduced the amount of UPF1 in S2 cells without affecting the levels of several other 119 
proteins we tested as controls (Figure 1B). 120 
UPF1 rapidly shuttles between nucleus and cytoplasm 121 
We examined the subcellular localization of immunostained UPF1 in Drosophila 122 
salivary glands, which are made up of large secretory cells with polytene nuclei. UPF1 123 
was most abundant in the cytoplasm and perinuclear region, and there was also 124 
distinct but less intense nuclear staining, mainly around the chromosomes and around 125 
the nucleolus (Figure 1D). A similar subcellular distribution of UPF1 was detected 126 
with the remaining two antibodies tested in wild-type salivary glands; and, the signal 127 
was drastically reduced in UPF1-RNAi glands, consistent with all three antibodies 128 
being specific (Figure 1-figure supplement 2A). Following cell fractionation of S2 129 
cells, α-tubulin and RNA Pol II were, as expected, restricted to the cytoplasmic and 130 
nuclear fractions, respectively – and a small proportion of the UPF1 co-purified with 131 
nuclei whilst most was in the cytoplasmic fraction (Figure 1C), consistent with the 132 
subcellular localisation detected by immunostaining.  133 
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UPF1 was also detected both in the cytoplasm and in the nucleus in other larval 134 
tissues, with varying immunostaining intensities. Perinuclear UPF1 was more 135 
apparent in salivary glands that are at a later stage of development (Figure 1-figure 136 
supplement 2A); and it was also obvious in Malpighian tubules and gut, which also 137 
showed an increased intra-nuclear UPF1 signal (Figure 1-figure supplement 3). In 138 
enterocytes (EC), staining was similar between the cytoplasm and the nucleus, while 139 
the most intense UPF1 signal was perinuclear (Figure 1-figure supplement 3B). The 140 
perinuclear presence was also apparent in salivary glands expressing UPF1-GFP, 141 
where UPF1 co-localised with binding of wheat germ agglutinin (WGA) – a lectin that 142 
predominantly interacts with O-GlcNAc-modified nuclear pore proteins 143 
(Mizuguchi-Hata et al., 2013) (Figure 1-figure supplement 2B). 144 
Since UPF1 is present both in the cytoplasm and nuclei, with relative quantities 145 
varying between cell-types, we wondered how rapidly UPF1 shuttles between cell 146 
compartments. We used two live cell imaging techniques – Fluorescence Loss in 147 
Photo-bleaching (FLIP) and Fluorescence Recovery after Photo-bleaching (FRAP) 148 
(Singh and Lakhotia, 2015) – to examine the mobility of GFP-UPF1 in salivary gland 149 
cells. FLIP revealed that sustained photobleaching of a small area of the cytoplasm 150 
led, within the continuously illuminated area, to an initial rapid decrease in 151 
GFP-UPF1fluorescence followed by a continued slower reduction.  Fluorescence also 152 
declined steadily both elsewhere in the cytoplasm, and, more slowly, within the 153 
nucleus (Figure 1E). These observations demonstrate ongoing diffusion of UPF1 154 
throughout the cytoplasm, and that nuclear UPF1 can leave the nucleus and enter the 155 
photodepletable cytoplasmic UPF1 pool at a fairly steady rate. The FRAP studies 156 
monitored the speed with which unbleached GFP-UPF1 diffuses into and repopulates 157 
a photobleached region of the cytoplasm or nucleus. Almost all of the UPF1 in each 158 
cell compartment was rapidly mobile, with the halftime for repopulation of each 159 
bleached area being only a few seconds (Figure 1F).  160 
UPF1 shuttling between the nucleus and the cytoplasm requires its RNA helicase 161 
activity  162 
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Nucleo-cytoplasmic shuttling has been reported in HeLa cells, with UPF1 163 
accumulating in the nuclei following treatment with leptomycin B (LMB) (Mendell et 164 
al., 2002), a drug that selectively inhibits CRM1-mediated protein export from the 165 
nucleus in most eukaryotes (Fukuda et al., 1997). We therefore explored the 166 
intracellular localisation and dynamics of a GFP-tagged UPF1 in Drosophila salivary 167 
glands; this (GFP-UPF1) showed a intracellular distribution similar to that of the 168 
endogenous protein, with an intense cytoplasmic signal and a weaker, but still 169 
obvious, signal in the regions occupied by the chromosomes (Figure 2A: left panel, 170 
the cytoplasmic texture of the salivary gland cells in these confocal images reflects the 171 
fact that they are packed with secretory vesicles at this stage of larval development). In 172 
glands treated with LMB for 60 minutes most of the GFP-UPF1 was observed within 173 
the nucleus, being largely excluded from the nucleolus (Figure 2A, right panels), 174 
suggesting that UPF1 exits from the nucleus, directly or indirectly, via a 175 
CRM1-dependent mechanism. This UPF1 redistribution was rapid in living glands: 176 
UPF1 was accumulating in the nucleus by the earliest time we could collect images 177 
(within ~5-6 min from adding LMB), and much of the cell’s UPF1 localised in the 178 
nucleus within half an hour (Figure 2-figure supplement 1A). 179 
Heat-shock caused a similar redistribution of much of UPF1 from the cytoplasm to the 180 
nucleus (Figure 2-figure supplement 1B, left panel), which was partially reversed 181 
when the tissue was returned to its normal temperature (Figure 2-figure supplement 182 
1B, right panel).  183 
Next, we examined whether the shuttling of UPF1 requires its RNA helicase activity 184 
in S2 cells transfected with constructs expressing either the wild-type or a mutant 185 
version of UPF1 with two amino acid substitutions (DE617AA) that inhibit its RNA 186 
helicase activity due to the loss of ATP hydrolysis (Bhattacharya et al., 2000). Both the 187 
wild type and the mutant proteins, tagged with GFP at either the N- or the C-terminal, 188 
were more abundant in the cytoplasm, as expected (Figure 2B, left panel). A portion of 189 
UPF1, the DA617AA mutant in particular, localised in bright fluorescent dots in the 190 
cytoplasm, possibly corresponding to P bodies (Brogna et al., 2008). However, whilst 191 
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the wild-type UPF1 relocalised to the nucleus following the LMB treatment, resulting 192 
in more UPF1 present in the nucleus than in the cytoplasm, the distribution of the 193 
DE617AA mutants was unaffected (Figure 2B, right panel).  194 
The data indicate that wild-type UPF1 is freely mobile within cell compartments and 195 
that it constantly moves in and out of the nucleus by mechanisms that involve the 196 
CRM1-dependent nuclear export pathway and requires its RNA helicase activity.  197 
UPF1 associates with transcribing regions of the chromosomes  198 
To gain insight into the role(s) of UPF1 in the nucleus, we used immunostaining to 199 
examine whether it associates with the polytene chromosomes of Drosophila salivary 200 
glands. These well-characterised giant interphase chromosomes are formed after 201 
multiple rounds of endoreplication without chromosomal segregation, and they 202 
provide a powerful system to visualise transcription and pre-mRNA processing at 203 
individual gene loci.  204 
UPF1 was present predominantly at interbands and puffs: cytologically distinct 205 
chromosome regions in which the chromatin is less condensed and that correspond to 206 
transcriptionally active sites (Figure 3A). The immunofluorescence signal appears to 207 
be specific, as: a) UPF1-RNAi drastically depletes the endogenous UPF1 208 
chromosomal signal (Figure 3-figure supplement 1A and Figure 3-figure supplement 209 
1B); b) the other two UPF1 antibodies produced a similar immunostaining banding 210 
pattern (Figure 3-figure supplement 1C); and, c) transgenically over-expressed 211 
UPF1-GFP, detected either by its fluorescence or with an anti-GFP antibody, also 212 
shows a similar banding pattern on the chromosomes (Figure 3-figure supplement 213 
1D).  214 
We then undertook double immunostaining of chromosomes for UPF1 and for Ser2 215 
Pol II – the form of Pol II that transcribes through the main body of genes which is 216 
characterised by having the C-terminal domain (CTD) of its largest subunit 217 
Ser2-phosphorylated (Boehm et al., 2003). Much of the UPF1 co-localized with Ser2 218 
Pol II, as would be expected from this type of banding pattern (Figure 3-figure 219 
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supplement 2A).  220 
The association of UPF1 with the chromosomes depends on transcription. This is 221 
illustrated by the changes in UPF1 immunostaining that followed heat-shock, which 222 
induces transcription at specific cytological puffs encoding heat-shock proteins and of 223 
hsrω lncRNAs at locus 93D (Lakhotia et al., 2012). This revealed a pattern of UPF1 224 
association at heat shock puffs and of detachment from most other transcription sites 225 
(Figure 3B). UPF1 was recruited to activated heat-shock genes that either contained 226 
(33B, 63B, 64F, 67B, 70A and 93D) or lacked (87A, 87C and 95D) introns (Figure 227 
3B). 228 
These observations suggested that UPF1 associates with genes that are being 229 
transcribed. UPF1 was also recruited to other genes following transcription activation, 230 
such as to an ecdysone-inducible transgene (S136 at chromosomal position 63B), at 231 
normal temperature (Choudhury et al., 2016). No UPF1 was found at this locus on the 232 
wild-type chromosome, but UPF1 was clearly associated with the transcription puff 233 
which was produced at this location following ecdysone activation of the transgene 234 
(Figure 3C).  235 
UPF1 mainly associates with Pol II transcription sites and depends on the 236 
nascent transcript 237 
We examined UPF1 and Ser2 Pol II association with multiple gene loci by chromatin 238 
immunoprecipitation (ChIP) of S2 cell extracts, followed by high-throughput DNA 239 
sequencing (ChIP-Seq). UPF1 was associated with many transcriptionally active 240 
genes, most of which are Pol II transcription sites. Figure 4A shows enrichment 241 
profiles of UPF1 and of Ser2 Pol II along a representative chromosome region. 242 
Actin5C provided a striking example of correspondence between the ChIP-seq and 243 
polytene immunostaining results: it was one of the most UPF1-enriched genes in the 244 
ChIP-seq data (Supplementary file 2, Figure 5-figure supplement 1B shows the UPF1 245 
ChIP-seq profile of Actin5C) and displayed one of the brightest UPF1 chromosomal 246 
signals at the gene locus corresponding to interband 5C on the X chromosome (Figure 247 
3A). The ChIP-seq data also show UPF1 association with a few Pol III genes 248 
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(Supplementary file 2, to be discussed later).  249 
The enrichment profile of UPF1 at Pol II loci closely followed that of Ser2 Pol II, and 250 
UPF1 enrichment being the greatest at highly expressed genes (Figure 4A; Figure 251 
4-figure supplement 2A and Figure 5-figure supplement 1 show additional examples 252 
of UPF1-enriched genes). A close correlation was observed between UPF1 and Ser2 253 
Pol II ChIP-seq signals, and also between UPF1-ChIP signals and mRNA levels 254 
(Figure 4B and 4C). Real-time PCR was used to validate the ChIP-seq data at several 255 
genes, both in S2 cells and salivary glands (Figure 4-figure supplement 1B and 1C; 256 
other examples are shown below). UPF1-RNAi led to a reduction in UPF1 enrichment 257 
at transcription sites, both confirming the specificity of the antibody and validating the 258 
ChIP protocol (Figure 4-figure supplement 1C). 259 
A metagene analysis of the ChIP-seq data shows that UPF1 is associated with genes, 260 
particularly with highly expressed genes (blue trace), and throughout their 261 
transcription units (Figure 4D), whereas Ser2 Pol II typically shows higher loading 262 
around transcription start sites (TSS) – corresponding to promoter-proximal Pol II 263 
pausing sites, as previously reported in Drosophila and other organisms (Adelman and 264 
Lis, 2012; Muse et al., 2007). Typically, most gene-associated UPF1 was further 265 
downstream than the TSS-proximal Ser2 Pol II peak, especially at highly expressed 266 
genes (Figure 4E). Striking examples of this pattern are the NAT1 and Su(z)2 genes 267 
(Figure 4A) and the α-Tub84B gene (Figure 4-figure supplement 2A, including some 268 
of the gene described further below.  269 
A comparison of the UPF1 loading of genes with different Ser2 Pol II loading profiles 270 
suggests that UPF1 association depends on transcription elongation: UPF1 did not 271 
associate with genes at which Ser2 Pol II was associated only with the TSS pausing 272 
site and which were not being actively transcribed (e.g. Adam TS-A, panel 5 in Figure 273 
4-figure supplement 2A). 274 
The association of UPF1 with Pol II transcription sites is partially sensitive to RNase 275 
treatment, suggesting that UPF1 binds nascent RNA. This was apparent both for 276 
immunostained UPF1 on polytene chromosomes (Figure 3-figure supplement 2B and 277 
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2C) and when assayed by ChIP/qPCR at specific genes in S2 cells (Figure 4-figure 278 
supplement 1D). UPF1 association was, though, less sensitive to RNase treatment 279 
than that of the RNA binding protein hnRNPA1 (Figure 3-figure supplement 2B and 280 
2C), which is almost completely detached from the chromosome following the same 281 
RNase treatment. Some of UPF1 co-purifies with Ser2 Pol II in a standard 282 
immunoprecipitation of S2 nuclear cell extracts, the interaction being again sensitive 283 
to RNase treatment (Figure 4-figure supplement 1E): less than that of hnRNPA1, but 284 
comparable to that of eIF4AIII, one of the exon junction complex (EJC) proteins that 285 
are loaded onto nascent RNAs (Choudhury et al., 2016). 286 
We also examined the effect of 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole 287 
(DRB) on salivary glands, a drug that blocks Pol II transcription by inhibiting Ser2 288 
phosphorylation (Bensaude, 2011). In the presence of DRB, unphosphorylated Pol II 289 
(Pol II) initiates transcription but does not engage in productive elongation as this 290 
would require Ser2-phosphorylated Pol II (Ser2 Pol II) (Adelman and Lis, 2012). 291 
DRB treatment, as expected, left interbands and puffs cytologically unaffected, 292 
however, it markedly reduced the amount of UPF1 associated with gene loci (Figure 293 
3-figure supplement 2D and 2E), providing further evidence that transcript elongation 294 
into the body of the gene is needed for this association to occur. DRB also reduced the 295 
association of UPF1 and Ser2 Pol II with genes, such as the highly expressed RpL23A, 296 
in S2 cells (Figure 4F). 297 
UPF1 at Pol III transcription sites 298 
UPF1 was found mainly at Pol II transcription sites, most of which are protein-coding 299 
genes, however, our ChIP-seq data revealed that UPF1 also binds at some Pol III 300 
genes. The latter included 7SK and both paralogous genes of 7SL snRNAs (Figure 301 
4-figure supplement 2B) – but not, for example, the much more numerous Pol 302 
III-transcribed tRNA genes (Figure 4-figure supplement 2C, Supplementary file 2).  303 
Intron recognition interferes with UPF1 nascent transcript association 304 
UPF1 was recruited both to intron-containing and intronless genes that were 305 
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undergoing transcription (Figure 5-figure supplement 1, and see also the earlier 306 
discussion of heat-shock gene activation), so recruitment did not depend on 307 
pre-mRNA splicing. Within intron-containing genes, however, more UPF1 was 308 
associated with exons than with introns – as can be seen in the ChIP-seq profiles of 309 
highly UPF1-enriched genes such as Xrp1 (Figure 5A; and Figure 5-figure 310 
supplement 1 shows other examples of genes displaying this pattern). Additionally, it 311 
appears that relatively more of UPF1 is associated with downstream exons than with 312 
the first exon, at Xrp1 as well as several of the other genes; notably, in many such 313 
cases most of the first exon corresponds to the 5’UTR (see examples in Figure 314 
5-figure supplement 1).   315 
This exon-biased UPF1 enrichment was confirmed by real time PCR in multiple ChIP 316 
experiments (at Xrp1 shown in Figure 5B; and Socs36E, not shown); and it is 317 
genome-wide, as demonstrated by comparing UPF1 association with introns and with 318 
their flanking exons in the ChIP-seq data from many genes (Figure 5C), UPF1 319 
enrichment is significantly higher for both the left (P = 6.737e-8) and the right 320 
flanking exon (2.391e-9); for details of how we corrected for possible bias in 321 
chromatin fragmentation or sequencing coverage, see Methods). This pattern is made 322 
visually apparent by plotting normalized enrichment in exons and introns, each scaled 323 
as a percentage of their full length (Figure 5D), and by comparing the density plots of 324 
normalised UPF1 enrichment values in introns and flanking exons, which show more 325 
values that are enriched in exons than introns (Figure 5-figure supplement 2A, 326 
compare red and yellow lines vs. the blue line in the right half of the graph).  327 
The lower frequency with which UPF1 associated with introns suggested that either 328 
splicing enhances binding to downstream exons or that intron recognition interferes 329 
with the UPF1 interaction (Figure 5-figure supplement 2B, Model 1 and Model 2 330 
respectively). We considered that 5’ splice sites (5’ss) at the start of introns, where the 331 
initial U1 snRNP spliceosome complex would bind, might act as road-blocks to UPF1 332 
translocation along nascent pre-mRNAs, hence, removal of U1 might allow UPF1 to 333 
move across the intron (Model 2). Consistent with this interpretation, the normal bias 334 
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towards UPF1-exon association in Xrp1 was abolished in U1-70K-depleted cells but 335 
persisted in cells depleted of eIF4AIII or Y14 (Figure 5-figure supplement 2C; a 336 
similar effect was observed at Socs36E, data not shown); Y14 and eIF4III are two EJC 337 
proteins that bind the nascent pre-mRNA but are not likely to play a direct splicing 338 
role in Drosophila; see (Choudhury et al., 2016). Moreover, genes with the most 339 
prominent exon-biased UPF1 enrichment, such as Xrp1, are efficiently 340 
co-transcriptionally spliced (see the Nascent RNA-seq profile in Figure 5A), whereas 341 
genes with no detectable exon-biased UPF1 enrichment, such as CG5059, are poorly 342 
co-transcriptionally spliced (Figure 5-figure supplement 1C) and are typically 343 
expressed at low levels, as reported (Khodor et al., 2011). It seems therefore, that 344 
intron recognition interferes with the association of UPF1 with the unspliced nascent 345 
transcript. 346 
UPF1 depletion leads to nuclear mRNA retention 347 
We also assessed whether depleting UPF1 in the salivary gland cells of 3rd instar 348 
larvae would have any effect on mRNA release from transcription sites and its 349 
subsequent processing and export from the nucleus.  350 
First we examined the overall cellular distribution of poly(A) RNA – which is referred 351 
to simply as poly(A) – by oligo(dT) FISH (fluorescence in situ hybridization): this 352 
should detect mRNA that has been transcribed, spliced, released from Pol II and 353 
polyadenylated. In wild-type cells poly(A) was abundant and fairly evenly distributed 354 
throughout the cytoplasm, as would be expected for mature mRNA, and there was 355 
relatively little in the nuclei (Figure 6A, panels I-III). By contrast, the nuclei of 356 
UPF1-depleted cells retained a substantial amount of poly(A), and the cells appeared 357 
to contain less cytoplasmic poly(A) than wild-type cells (Figure 6A, panels IV-VI). 358 
Much of the nuclear-retained poly(A) in the UPF1-depleted cells formed large 359 
cluster(s) in either inter-chromosomal spaces (Figure 6A, panel VI, white arrow) or, 360 
possibly more frequently, in surrounding nucleoli (yellow arrow) that seemed neither 361 
linked to or in the proximity of any specific chromosomal region(s) or defined 362 
transcription site(s). In salivary glands over-expressing a transgene encoding human 363 
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UPF1 there was no such nuclear poly(A) accumulation (Figure 6A, panels VII-IX); 364 
indicating that this phenotype is a direct consequence of the absence of UPF1. 365 
Additionally, no poly(A) accumulation was observed in UPF31 mutant glands, or 366 
following RNAi depletion of the EJC components Y14 or MAGO (unpublished data). 367 
Expression of hUPF1 also suppressed the apparent smaller size of the salivary glands 368 
depleted of the endogenous UPF1; these glands were comparable in size to that of 369 
wild-type (Figure 6A, panels I and VII vs IV).  370 
An appreciable amount of poly(A) signal, which was not within clusters, was clearly 371 
at the chromosomes though, in the UPF1-depleted cells (Figure 6A, panels III and VI). 372 
We therefore used oligo(dT) FISH on polytene chromosome spreads to compare 373 
wild-type and UPF1-depleted cells and to assess whether there is retention of poly(A) 374 
near transcription sites. There was little poly(A) associated with most of the wild-type 375 
chromosomes. However, a few interbands – such as 2C at the distal end of the X 376 
chromosome (Figure 6B) – showed clear poly(A) signals (Figure 6B, left panel), 377 
suggesting that some mature mRNAs that have been cleaved and polyadenylated 378 
remain associated, at least briefly, with some transcription sites. Additionally, since 379 
UPF1 was obviously not associated with 2C (see Figure 3A), the poly(A) 380 
accumulation at 2C in wild-type cells may be a consequence of lack of UPF1 at this 381 
transcription site.  382 
Both the number of transcriptional sites showing poly(A) accumulation and the 383 
amount of poly(A) RNA associated with these sites were strikingly increased in 384 
UPF1-depleted cells (Figure 6B, right panel). For example, there was no visible 385 
poly(A) accumulation at site 5C, which corresponds to the highly transcribed Actin5C 386 
gene, in wild-type, but this band was obviously fluorescent in UPF1-depleted cells. 387 
Another example was site 2B – where constitutively expressed sta and rush are 388 
probably the most active genes at this larval stage – which showed a faint poly(A) 389 
signal in wild-type glands and a strong signal in UPF1-depleted cells. UPF1 was 390 
clearly associated with these transcription sites (2B and 5C) on polytene 391 
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chromosomes (Figure 3A) and in S2 cells (as detected by ChIP: see Supplementary 392 
file 2 and Figure 5-figure supplement 1 for the UPF1 profile of Actin5C).  393 
Cumulatively, the data indicate that UPF1 plays important role(s) in the release of 394 
mRNAs from transcription sites and in their transport out of the nucleus (Figure 6C 395 
shows a cartoon of a transcription site in either a wild-type or UPF1 depleted cell with 396 
or without mRNA retention). 397 
398 
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Discussion 399 
The RNA helicase UPF1 is typically most abundant in the cytoplasm and is mainly 400 
discussed in relation to NMD, leading to the common assumption that it acts mainly 401 
on mRNPs that have been exported from the nucleus. In contrast, we present evidence 402 
that UPF1 moves constantly within and between cell compartments, and that this 403 
shuttling depends on the ATPase activity of the RNA helicase domain, which is 404 
required for the dynamic binding and dissociation of UPF1 from mRNAs in both yeast 405 
and mammalian cells (Bhattacharya et al., 2000; Franks et al., 2010). Notably, UPF1 406 
ATPase domain resides within a region previously thought to contain an atypical 407 
nuclear localisation signal in mammalian cells, which when deleted, abolished nuclear 408 
UPF1 accumulation following LMB treatment (Mendell et al., 2002). However, in 409 
view of UPF1 ATPase activity being required for this shuttling, we propose that 410 
typical UPF1 subcellular distribution, with more of the protein present in the 411 
cytoplasm than in the nucleus, is primarily a consequence of its continued association 412 
with abundant RNA cargos that are being continuously exported out of the nucleus. 413 
The NES-dependent CRM1 export pathway is not a major mRNA nuclear export 414 
mechanism in Drosophila nor in other well-studied organisms (Herold et al., 2003; 415 
Hutten and Kehlenbach, 2007), yet it is required for the export of vastly more 416 
abundant cargos consisting of RNP particles like ribosomal subunits and the signal 417 
recognition particle (SRP) (Hutten and Kehlenbach, 2007). Our data indicate that 418 
UPF1 might bind with SRP, as it strongly associated with the two loci encoding the 419 
7SL RNA (Figure 4-figure supplement 2B), which make the SRP scaffold. However, 420 
UPF1 may not be binding the individual 40S and 60S subunits, as less UPF1 is 421 
detected in the centre of the nucleolus than in the remainder of the nucleus - discussed 422 
further below. 423 
Within the nucleus we found UPF1 associated with many actively transcribing Pol II 424 
sites, to which it seems mainly to be recruited by an interaction with nascent 425 
pre-mRNA. More of the transcript-tethered UPF1 is associated with exons than with 426 
flanking introns. Splicing might enhance UPF1 binding, particularly with downstream 427 
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exons (Figure 5-figure supplement 2B, Model 1), however, since UPF1 also associates 428 
with intron-less genes, splicing may not be necessary for its loading on nascent 429 
transcripts. The mechanism responsible for UPF1 being associated more with exons 430 
than with introns remains therefore to be elucidated. Possibly, UPF1 associates with 431 
all Pol II nascent transcripts, but on intron-containing pre-mRNAs, splice site 432 
recognition interferes with intron binding. Consistent with this interpretation, in the 433 
two genes we examined (Xrp1 and Socs36E), the exon vs. intron bias in UPF1 binding 434 
is lost in cells depleted of the spliceosome component U1 snRNP. This suggests that, 435 
when U1 snRNP is bound to the 5’ss of an intron at the initial stage of splicing, it may 436 
hinder UPF1 translocation along the pre-mRNA and cause it to dissociate (see the 437 
Model 2 we propose in Figure 5-figure supplement 2B). UPF1 scanning of 438 
pre-mRNAs may therefore influence 5’ splice sites recognition and affect splicing 439 
directly; changes in the relative concentrations of many alternatively spliced 440 
transcripts have been reported in UPF1-depleted S2 cells (Brooks et al., 2015).  441 
Simple affinity of UPF1 for RNA is not likely to be the primary reason why UPF1 442 
associates with some nascent transcripts, for several reasons: UPF1 does not associate 443 
with some highly transcribed Pol II genes, such as spliceosomal snRNAs; nor with 444 
snRNA U6 or other highly active Pol III genes; nor with rRNA genes transcribed by 445 
Pol I; there would be no differential affinity for introns vs. exons within a transcript; 446 
and UPF1 appears to be excluded from the RNA-packed centre of the nucleolus where 447 
rRNA genes are transcribed and ribosomal subunits are assembled (McLeod et al., 448 
2014). What features of some nascent transcripts, most often of Pol II-transcribed 449 
genes, dictate that UPF1 becomes associated with them remain to be determined. One 450 
possible candidate would be the 7-methylguanosine (m7G) cap that is added 451 
co-transcriptionally to the 5’end of pre-mRNAs but not to Pol I and Pol III transcripts 452 
(Ghosh and Lima, 2010). Moreover, the m7G caps added to snRNAs and other small 453 
non-mRNA Pol II transcripts are further modified though by hypermethylation to 454 
generate 2,2,7-trimethylguanosine(m(3)G) structures (Mouaikel et al., 2002). 455 
Although this hypermethylation occurs after the transcripts have been exported to the 456 
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cytoplasm in mammalian cells, perhaps this modification may occur in the nucleus 457 
instead in other organisms (Mouaikel et al., 2002), and this might explain why these 458 
classes of transcripts are not associated with UPF1 in Drosophila. 459 
The association of UPF1 with nascent transcripts seems to be dynamic, and its 460 
putative 5’-to-3’ scanning along RNA is likely to be fast and, at least on 461 
intron-containing pre-mRNAs, discontinuous. This pattern also suggests that when it 462 
encounters a steric block that cannot be removed, UPF1 must be capable of quickly 463 
dissociating and re-loading elsewhere on the transcript. In vitro, UPF1 can translocate 464 
along RNAs over long distances – but only at a maximum scanning velocity of ~80 465 
base/min (Fiorini et al., 2015), which is much slower than the 2-3 kb/min of Pol II 466 
(Fiorini et al., 2015; Fukaya et al., 2017). Therefore, UPF1 either translocates along 467 
RNA faster in vivo, or its scanning is not processive as envisaged, or it is factually 468 
piggybacking on another entity that is capable of translocating on the RNA faster than 469 
UPF1. Although this machinery is unlikely to be the Pol II itself, as we found no 470 
evidence of a strong direct association of Pol II with UPF1.  471 
Notably, we observed that less of UPF1 is associated with the 5’ proximal region of 472 
nascent transcripts, which, in some instances, coincides with the 5’UTR (see Actin5C 473 
in Figure 5-figure supplement 1B). 5’UTRs are defined by the process of translation 474 
initiation, in which, following association with the mRNA’s 5’ cap, the 40S (carrying 475 
the initiator tRNA) migrates downstream until it recognises the start codon (Kozak, 476 
1989). Less association of UPF1 with 5’UTRs might therefore signify that its binding 477 
to nascent transcripts is translation dependent, at least in some instances, and supports 478 
the view that ribosomes start scanning mRNAs cotranscriptionally; evidence of which 479 
has previously been reported in Drosophila (Al-Jubran et al., 2013; Brogna et al., 480 
2002).  481 
The most striking effects of UPF1 depletion were retention of poly(A) RNA at  482 
transcription sites and then its failure to be exported effectively from the nucleus. 483 
Mature mRNAs that have been cleaved and polyadenylated are normally expected to 484 
be speedily released from transcription sites, but our data show that this is not always 485 
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the case. We have both: a) identified some sites on polytene chromosomes that 486 
apparently accumulate poly(A) RNA even in wild-type glands; and b) shown that most 487 
of the active Pol II genes accumulate poly(A) RNA in UPF1-depleted salivary glands. 488 
Poly(A) RNA accumulation in UPF1-depleted cells is most prominent at genes with 489 
which UPF1 associates strongly in wild-type, such as Actin5C (shown both 490 
microscopically and by ChIP-seq). Conversely, those few transcription sites at which 491 
poly(A) accumulates even in wild-type cells, may not normally be associated with 492 
UPF1, a striking example of which is the 2C transcription site on the polytene 493 
chromosomes, where poly(A) accumulation was most apparent, but no obvious UPF1 494 
association was observed.  495 
Evidence of retention of poly(A) and specific mRNAs in discrete nuclear foci or 496 
“dots” has previously been reported in cells defective in RNA processing, initially in 497 
mRNA export and processing mutants in yeast (Jensen et al., 2001); and later in other 498 
cells in which one of several RNA processing reactions are impaired (Abruzzi et al., 499 
2006; Paul and Montpetit, 2016), including Drosophila cells carrying mutation in the 500 
RNA helicase P68 (Buszczak and Spradling, 2006). Whether the previously described 501 
“dots” correspond to the poly(A) clusters that accumulate in the inter-chromosomal 502 
spaces of UPF1-depleted nuclei and/or to accumulations of poly(A) at transcription 503 
sites, which we identified here, remains to be determined.  504 
In summary, our results indicate that UPF1 plays an important genome-wide role in 505 
the release of mRNAs from transcription sites and their export to the cytoplasm, at 506 
least in Drosophila salivary gland cells. Possibly, in the absence of UPF1 function, 507 
mRNPs acquire or retain native conformations that hinder their release from the 508 
chromosome and make them prone to aggregation and, consequently, cause nuclear 509 
retention. Such a global role of UPF1 could explain, better than its involvement in 510 
NMD, why this protein is universally conserved in eukaryotes, why its depletion 511 
affects the expression of a large fraction of the genome, and possibly why expression 512 
of human UPF1 in rat models of amyotrophic lateral sclerosis (ALS) overcomes the 513 
pathology caused by over-expression or mutation of the RNA-binding protein TDP-43 514 
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(Barmada et al., 2015; Jackson et al., 2015).  515 
516 
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Materials and Methods 517 
Antibodies 518 
The following antibodies were used for immunostaining: mouse anti-UPF1 (described 519 
as 7B12, 7D17 and 1C13 in this paper, typically diluted 1:100), mouse IgM anti-Ser2 520 
Pol II (AB_10143905, H5, Covance, 1:500), mouse anti-hnRNPA1 (Hrb87F, P11, 521 
1:50) (Hovemann et al., 1991), mouse anti-GFP (AB_627695, B-2, Santa Cruz, 522 
1:200), Tetramethylrhodamine Conjugate Wheat Germ Agglutinin (Thermo Fisher, 523 
W7024, 10µg/mL). The antibodies used in Western blotting: mouse anti-UPF1 (7B12, 524 
1:1000), mouse anti-α-tubulin (AB_477579, Sigma- Aldrich, 1:2500), rat anti-Ser2 525 
Pol II (AB_11212363, Merck Millipore, 1:5000), mouse anti-hnRNPA1 (P11, 1:200), 526 
rabbit anti-eIF4AIII (1:1000), rabbit anti-Y14 (1:1000); the last two antibodies were 527 
described previously (Choudhury et al., 2016). The antibodies used in ChIP are mouse 528 
anti-UPF1 (7B12, see below, 5-10 µg), rabbit anti-Ser2 Pol II (AB_304749, Abcam, 529 
ab5095, 5 µg), mouse anti-Pol II (AB_306327, Abcam, ab817, 5µg) and mouse 530 
anti-GFP (AB_627695, B-2, Santa Cruz, 5 µg). 531 
Drosophila Stocks 532 
Flies were reared in standard corn meal fly food media at 24°C. The y w1118 strain was 533 
used as wild type (DGGR_108736). UAS-UPF1-RNAi (43144) and UAS-GFP-UPF1 534 
(24623) were obtained from the Bloomington stock centre. The forkhead (Fkh) Gal4 535 
has a salivary gland specific expression from early stage of development (Henderson 536 
and Andrew, 2000). The UPF31 mutant was previously described (Avery et al., 2011). 537 
The transgenes expressing the lacO-tagged and ecdysone inducible S136 construct was 538 
described before (Choudhury et al., 2016). The transgene expressing human UPF1 539 
(UAS-hUPF1) was generated by cloning the cDNA encoding wild-type human UPF1 540 
into the EcoRI and NotI restriction sites in pUAST vector (Brand and Perrimon, 1993); 541 
after sub-cloning it from pCI-neo-hUPF1, previously described (Sun et al., 1998) into 542 
the NheI and SpeI sites in pBluescript. The UAS-UPF1-RNAi targets the following 543 
sequence located in the middle region of Drosophila UPF1: 544 
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CCGGTTGTTATGTGCAAGAAA, which is significantly divergent in human UPF1 545 
(CCAGTGGTGATGTGCAAGAAG) so that it cannot be targeted by this RNAi 546 
construct, as demonstrated in Results.   547 
Cell culture, RNA interference and Transfection 548 
S2 cells (CVCL_Z232) were cultured in Insect–XPRESS media (Lonza) 549 
supplemented with 10% Fetal Bovine Serum (FBS) and 1% 550 
Penicillin-Streptomycin-Glutamine mix (P/S/G, Invitrogen) at 27°C. These cells 551 
never tested mycoplasma positive. To make the RNAi constructs for UPF1, eIF4AIII, 552 
Y14 and snRNPU1-70k mRNA, the specific sequences were PCR amplified from S2 553 
cell genomic DNA, using corresponding primer pairs (Supplementary file 3). Along 554 
with the desired gene sequence, all the primer pairs carried the T7 promoter sequence 555 
(in bold) at their 5’ end (5’-TTAATACGACTCACTATAGGGGAGA-3’). The 556 
amplified PCR fragments were purified using Monarch® PCR and DNA Cleanup Kit 557 
(T1030S, NEB) and dsRNA was synthesized using the T7 RiboMAX express RNAi 558 
system (P1700, Promega). To induce RNAi, a six-well culture dish was seeded with 559 
106 cells/well in serum-free media and mixed with 15 µg of dsRNA/well. Following 1 560 
hr incubation at RT, 2 mL of complete media was added to each well and the cells were 561 
incubated for the next three days to knockdown the corresponding RNA and then 562 
harvested. The RNAi efficiency of UPF1, eIF4AIII and Y14 was measured by 563 
Western blotting while snRNPU1-70k was measured by real time PCR.  564 
The four plasmids (B306, pAGW-N-term-GFP-UPF1; B307, 565 
pAc-C-term-GFP-UPF1; B309, pAGW-N-term-GFP-UPF1(DE-AA); and B310, 566 
pAc-C-term-GFP-UPF1(DE-AA) expressing Drosophila UPF1 tagged with GFP 567 
were generated by inserting the coding region of either wild-type UPF1 or 568 
UPF1(DE617AA) in either pAc (GFP at the C-terminal) or pAGW (GFP at the 569 
N-terminal) Gateway compatible vector carrying a Act5C promoter sequence, as 570 
previously described (The Drosophila Gateway Vector collection, Carnegie Institution 571 
for Science). The coding region was PCR amplified from a full length Drosophila 572 
UPF1 cDNA clone previously described (Brogna, 2000); and the mutation was 573 
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inserted using the QuikChange® site-directed mutagenesis (Stratagene). 574 
Transfections were typically performed using TransIT-2020 transfection reagent 575 
(MIR5400) and cells were incubated for 24 hrs at 270C before further usage. For 576 
Leptomycin B (LMB) treatment, the cells were incubated with 50 nM LMB for 1 hr at 577 
RT.   578 
Generation of monoclonal antibodies against Drosophila UPF1 579 
Antigens design, preparation, mice immunization and hybridoma generation were 580 
carried out by Abmart (Shanghai). Twelve peptide sequences predicted to be highly 581 
immunogenic were selected from D. melanogaster UPF1 (Supplementary file 1) and 582 
cloned in-frame into an expression vector to produce a recombinant protein 583 
incorporating all 12 antigens which were used as the immunogen (Abmart, SEALTM 584 
technology). Hybridoma clones were generated and used to induce 18 ascites, which 585 
were then screened by Western blotting of S2 cell protein extracts. Out of these, three 586 
that showed a single band of the expected size and minimal cross-reactivity were 587 
selected and more of the monoclonal antibodies were subsequently purified from the 588 
corresponding hybridoma cell culture in vitro. Unless otherwise specified, 7B12 was 589 
used as the anti-UPF1 antibody throughout this study. 590 
Larval tissue immunostaining 591 
Whole-mount immunostaining was performed as previously described (Choudhury et 592 
al., 2016). In brief, the internal organs of 3rd instar larvae were dissected in 1X PBS 593 
(13 mM NaCl, 0.7 mM Na2HPO4, 0.3 mM NaH2PO4, pH 7.4) and fixed in 4% 594 
formaldehyde for 20 minutes at RT. Tissues were washed in 1XPBS followed by 1% 595 
Triton X-100 treatment for 20 minutes. Tissues were washed and incubated in 596 
blocking solution (10% Fetal Bovine Serum (FBS), 0.05% Sodium Azide in 1X PBS) 597 
for 2 hrs at RT and then incubated in primary antibodies at 40C overnight. Tissues 598 
were washed and further incubated with appropriate fluorescent-tagged secondary 599 
antibodies for 2 hrs, typically. After washing, tissues were incubated in DAPI (4–600 
6-diamidino-2-phenylindole, Sigma-Aldrich, 1 μg/mL) for 10 minutes and mounted in 601 
PromoFluor Antifade Reagent (PK-PF-AFR1, PromoKine) mounting medium and 602 
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examined using a Leica TCS SP2-AOBS confocal microscope. 603 
LMB, DRB and larvae heat shock treatment 604 
Wandering 3rd instar larvae were dissected in M3 media and tissues were incubated 605 
with or without Leptomycin B (LMB, 50 nM) for 1 hr at RT. To examine the real-time 606 
effect of LMB treatment in the living cell, salivary glands were dissected in M3 media 607 
and incubated with a hanging drop of 50 nM LMB in M3 media in a cavity slide 608 
(Singh and Lakhotia, 2015). The fluorescence signal was acquired at 5-minute 609 
intervals with a Leica TCS SP2-AOBS confocal microscope. For ecdysone treatment, 610 
salivary glands were dissected in M3 media and incubated in 20-hydroxyecdysone 611 
(Sigma-Aldrich, H5142, 1µM) for 1 hr at RT. For RNase treatment, salivary glands 612 
were dissected in M3 media and incubated in 0.1% Triton X-100 for 2 minutes prior to 613 
adding RNase A (Invitrogen, 100µg/mL) and performing 1 hr incubation at RT. To 614 
examine the effect of 5, 6-Dichlorobenzimidazole 1-β-D-ribofuranoside (DRB) 615 
treatment, salivary glands were dissected in M3 media and incubated with DRB 616 
(Sigma-Aldrich, 125µM) for 1 hr at RT. For heat shock response, larvae were placed 617 
in a pre-warmed microfuge tube lined with moist tissue paper and incubated in 618 
water-bath maintained at 37+10C for 1 hr.  619 
Live cell imaging (FRAP and FLIP) 620 
Fluorescence recovery after photobleaching (FRAP) and fluorescence loss in 621 
photobleaching (FLIP) methods have been previously described (Klonis et al., 2002).  622 
Salivary glands expressing GFP-UPF1were dissected from 3rd instar larvae and 623 
mounted as a hanging drop in M3 media. For the FRAP the region of interest (ROI, a 624 
circle of fixed diameter) was rapidly photobleached with 100 iterations of 100% 625 
power Argon laser (488 nm) exposure. Subsequent recovery of fluorescence in the 626 
photobleached region was examined at defined time intervals. Fixed cells were 627 
examined as a control to confirm irreversible photobleaching. FRAP experiments 628 
were carried out on salivary glands at room temperature. The fluorescence signal in 629 
ROI was normalized and data analysed following published methods (Phair and 630 
Misteli, 2000; Singh and Lakhotia, 2015). FLIP experiments were done as previously 631 
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described (Phair and Misteli, 2000). Following acquisition of five control images, 632 
GFP fluorescence in ROI1 was continuously photobleached with Argon laser (488 633 
nm) at 100 % power by 50 iterations. The loss in fluorescence in another region of 634 
interest, the ROI2 was measured for the same length of time. Fluorescence intensities 635 
at ROI1 and ROI2 were normalized and data analysed as described (Nissim-Rafinia 636 
and Meshorer, 2011). Both photobleaching experiments have been done using a Leica 637 
TCS SP2-AOBS confocal microscope. 638 
Polytene Chromosomes Immunostaining 639 
Apart from the changes detailed below, the procedure was mostly as previously 640 
described (Rugjee et al., 2013). Briefly, actively wandering 3rd instar larvae were 641 
dissected in 1X PBS and salivary glands were first fixed with 3.7% formaldehyde in 1X 642 
PBS and then with 3.7% formaldehyde in 45% acetic acid for 1 min each (Singh and 643 
Lakhotia, 2012). For Pol II immunostaining, salivary glands dissected in 1XPBS were 644 
incubated directly with 3.7% formaldehyde in 45% acetic acid for 3 minutes. Salivary 645 
glands were squashed in the same solution under the coverslip. Slides were briefly 646 
dipped in liquid nitrogen, the coverslips were flipped off with a sharp blade and then 647 
immediately immersed in 90% ethanol and stored at 40C. For immunostaining, the 648 
chromosomes were air dried and then rehydrated by incubating the slide with 1XPBS in 649 
a plastic Coplin jar. Chromosomes were incubated in blocking solution (as for the tissue 650 
immunostaining) for 1 hr at RT and then incubated with primary antibodies diluted in 651 
blocking solution in a humid chamber overnight at 40C.  Chromosomes were washed in 652 
1X PBS three times and further incubated with appropriate fluorescent-tagged 653 
secondary antibodies diluted in blocking solution for 2 hrs at RT in the humid chamber. 654 
After washing, chromosomes were counterstained with DAPI and mounted in 655 
PromoFluor mounting media. Chromosomes were examined under Nikon Eclipse Ti 656 
epifluorescence microscope, equipped with ORCA-R2 camera (Hamamatsu 657 
Photonics).  658 
Fluorescent Oligo (dT) in situ hybridization (FISH) 659 
Oligo (dT) FISH was done as previously described for mammalian cells with some 660 
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modifications (Tripathi et al., 2015). Salivary glands of 3rd instar larvae were dissected 661 
in 1XPBS and fixed in 4% formaldehyde for 15 min at RT. Glands were then washed 662 
in 1XPBS and incubated with 0.1% Triton X-100 with 1U/µL Ribolock RNase 663 
Inhibitor (ThermoFisher Scientific, EO0381) in 1XPBS for 10 min on ice and then 664 
rinsed further with 1XPBS three times with 5 min intervals and with 2XSSC for 10 665 
min. Salivary glands were incubated with 5ng/µL rhodamine-labelled oligo(dT)45 666 
probe (IDT) in hybridization solution (25% Formamide, 2X SSC pH 7.2, 10% w/v 667 
Dextran sulfate (Sigma Aldrich), 1 mg/mL E. coli tRNA (Sigma-Aldrich, R1753) for 668 
12 hrs at 420C. Glands were then washed with freshly made wash buffer (50% 669 
Formamide in 2XSSC pH 7.2), followed by 2XSSC, 1XSSC and finally with 1XPBS 670 
3 times each, with 5 min interval. Nuclei were counterstained with DAPI and tissues 671 
were mounted in PromoFluor Antifade mounting medium and examined under Leica 672 
TCS SP2-AOBS confocal microscope. 673 
For polytene chromosomes oligo(dT) FISH, salivary glands were dissected in 1XPBS 674 
and incubated with fixing solution (1.85% formaldehyde in 45% acetic acid) for 5 min 675 
at RT. Chromosomes were squashed in the same solution and examined immediately 676 
under phase-contrast microscope to check if properly spread. Slides with good 677 
chromosomes were briefly dipped in liquid nitrogen and the coverslips were flipped 678 
off with a sharp blade. Slides were immediately dipped in 90% alcohol and stored at 679 
40C. Before hybridization, slides were air dried and rehydrated in 1XPBS and then 680 
washed and hybridized, as described above for whole salivary glands. Chromosomes 681 
were counterstained with DAPI, mounted in PromoFluor Antifade mounting medium 682 
and examined under Nikon Eclipse Ti epifluorescence microscope. 683 
684 
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Immunoprecipitation 685 
Immunoprecipitation was performed as previously described (Hintermair et al., 2016), 686 
with some modifications as detailed below. S2 cells (4 X 107) were harvested and 687 
washed with ice-cold 1X PBS containing 1X PhosSTOP (Roche, 04906845001) and 688 
1X cOmplete™, Mini, EDTA-free Protease Inhibitor Cocktail (Roche, 04693159001). 689 
Cells were incubated in the hypotonic AT buffer (15 mM HEPES pH 7.6, 10 mM KCl, 690 
5mM MgOAc, 3mM CaCl2, 300 mM Sucrose, 0.1% Triton X-100, 1mM DTT, 1X 691 
PhosSTOP, 1X cOmplete™, Mini, EDTA-free Protease Inhibitor Cocktail and 1U/µL 692 
Ribolock RNase Inhibitor) for 20 min on ice and lysed with 2mL Dounce 693 
homogenizer by 30 strokes with the tight pestle. Lysate was centrifuged at 5000 RPM 694 
for 5 min at 40C in microcentrifuge and the nuclear pellet was resuspended in 500 μL 695 
IP buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% NP-40 (Roche), 1X PhosSTOP, 696 
1X cOmplete™, Mini, EDTA-free Protease Inhibitor Cocktail, 1U/µL Ribolock 697 
RNase Inhibitor) for 20 min on ice. Nuclear lysates were sonicated using a Bioruptor 698 
sonicator (Diagenode) for 3 cycles of 30 sec ON and 30 sec OFF with maximum 699 
intensity. Following sonication, the lysates were centrifuged at 13000 RPM for 15 min 700 
at 40C in a microfuge and the antibody (5μg) was added to the clear supernatant, with 701 
or without addition of RNase A (100µg/mL), and incubated overnight at 40C on a 702 
rocker. Following incubation, 20 μL of prewashed paramagnetic Dynabeads 703 
(ThermoFisher Scientific, 10004D) were added and incubated further for 2 hrs at 40C 704 
on a rocker. Beads were washed 5 times with IP buffer using a magnetic rack and 705 
proteins were extracted by adding 40μL SDS-PAGE sample buffer.  706 
ChIP-Seq 707 
S2 cells (2 X 10
7
) were harvested and fixed with 1% formaldehyde (EM grade, 708 
Polyscience) for 10 min at RT. Following fixation, cross-linking reaction was stopped 709 
by adding 125 mM Glycine for 5 min at RT. Cells were centrifuged at 2000 RPM for 5 710 
min at 4°C, the pellet was washed twice with ice-cold 1X PBS containing 1X 711 
cOmplete™, Mini, EDTA-free Protease Inhibitor Cocktail. The cell pellet was 712 
resuspended in 1 mL of cell lysis buffer (5mM PIPES pH 8.0, 85mM KCl, 0.5% 713 
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NP-40) supplemented with 1X cOmplete™, Mini, EDTA-free Protease Inhibitor 714 
Cocktail and 1X PhosStop and incubated for 10 min at 4
0
C. Cells were centrifuged 715 
and the pellet was resuspended in 1 mL nuclear lysis buffer (50mM Tris pH 8.0, 10 716 
mM EDTA, 1.0% SDS) supplemented with 1X cOmplete™, Mini, EDTA-free 717 
Protease Inhibitor Cocktail and 1X PhosStop and incubated for 10 min at 4
0
C. The cell 718 
suspension was further diluted with 500 µL IP dilution buffer (16.7 mM Tris pH 8.0, 719 
1.2 mM EDTA, 167 mM NaCl, 1.1% Triton X-100, 0.01% SDS) and sonicated for 5 720 
cycles at 30sec ON, 30 sec OFF at maximum intensity using a Bioruptor sonicator 721 
(Diagenode); this produced an average fragment size of ~500 bp. Samples were 722 
centrifuged at 13000 RPM for 20 min in a microcentrifuge and the clear supernatant 723 
was transferred to a 15 mL tube. An aliquot of 100 µL supernatant was kept to extract 724 
input DNA. The supernatant was further diluted with 5 volume of IP dilution buffer.  725 
For each ChIP, typically we added 5 to 10 µg of antibody to this supernatant and 726 
incubated overnight at 4
0
C on a rocker. Prewashed 20 µL Dynabeads were added to 727 
the lysate-antibody mix and incubated further for 1 hr at 4
0
C on a rocker. Beads were 728 
washed 6 times with low salt buffer (0.1% SDS, 1% Triton X-100, 2mM EDTA, 20 729 
mM Tris pH 8.0, 150 mM NaCl), once with high salt buffer (0.1% SDS, 1% Triton X 730 
100, 2mM EDTA, 20 mM Tris pH 8.0, 500 mM NaCl) and once with 1X TE buffer 731 
(10mM Tris pH 8.0, 1mM EDTA). The beads were then incubated with 250 µL 732 
elution buffer (0.1M NaHC03, 1% SDS) at RT for 15 min and eluted chromatin was 733 
reverse cross-linked by adding 38 µL de-crosslinking buffer (2M NaCl, 0.1M EDTA, 734 
0.4M Tris pH 7.5) and then incubated at 65°C overnight on a rotator. Proteins were 735 
digested by adding 2 µL Proteinase K (50 mg/mL) and incubated at 50
0
C for 2 hrs on 736 
a rocker. DNA was isolated using Monarch® PCR and DNA Cleanup Kits. Real-time 737 
PCR quantification of DNA samples was carried out using the SensiFAST SYBR 738 
Hi-ROX Kit (Bioline, BIO-92005) in 96-well plates using an ABI PRISM 7000 739 
system (Applied Biosystems). For NGS sequencing, ChIP and input DNA were 740 
further fragmented to 200 bp fragment size using a Bioruptor Pico (Diagenode). All 741 
ChIP-DNA libraries were produced using the NEBNext Ultra II DNA Library Prep 742 
Kit (New England Biolab E7645L) and NEBnext Multiplex Oligos for Illumina Dual 743 
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Index Primers (New England Biolabs E7600S), using provided protocols with 10ng of 744 
fragmented ChIP DNA. Constructed libraries were assessed for quality using the 745 
Tapestation 2200 (Agilent G2964AA) with High Sensitivity D1000 DNA ScreenTape 746 
(Agilent 5067-5584). Libraries were tagged with unique barcodes and sequenced 747 
simultaneously on a HiSeq4000 sequencer. 748 
Nascent RNA isolation from S2 cells 749 
Nascent RNA isolation was performed as previously described (Khodor et al., 2011). 750 
Briefly, S2 cells (4 X 107) were harvested and washed twice with ice-cold 1X PBS via 751 
centrifugation at 2000g for 5 min each. Cells were resuspended in 1 mL ice-cold 752 
buffer AT and incubated on ice for 10 minutes. Cells were lysed using a 2mL Dounce 753 
homogenizer by 30 strokes with the tight pestle. The lysate was divided into two 754 
aliquots and each aliquot of 500 µL was layered over a 1mL cushion of buffer B (15 755 
mM HEPES-KOH at pH 7.6, 10 mM KCl, 5 mM MgOAc, 3 mM CaCl2, 1 M sucrose, 756 
1 mM DTT, 1X cOmplete™, Mini, EDTA-free Protease Inhibitor Cocktail), and 757 
centrifuged at 8000 RPM for 15 min at 4°C in a microcentrifuge. The supernatant was 758 
removed and the pellet was resuspended in 5 volumes of nuclear lysis buffer (10 mM 759 
HEPES-KOH pH 7.6, 100 mM KCl, 0.1 mM EDTA, 10% Glycerol, 0.15 mM 760 
Spermine, 0.5 mM Spermidine, 0.1 M NaF, 0.1 M Na3VO4, 0.1 mM ZnCl2, 1 mM 761 
DTT, 1X cOmplete™, Mini, EDTA-free Protease Inhibitor Cocktail and 1U/µL 762 
Ribolock RNase Inhibitor) and resuspended using a 2mL Dounce homogenizer by 3 763 
strokes with loose pestle and 2 strokes with tight pestle. Equal volume of 2X NUN 764 
buffer (50 mM HEPES-KOH pH 7.6, 600 mM NaCl, 2 M Urea, 2% NP-40, 1 mM 765 
DTT, 1X cOmplete™, Mini, EDTA-free Protease Inhibitor Cocktail and 1U/µL 766 
Ribolock RNase Inhibitor) was added to the nuclear suspension drop by drop while 767 
vortexing and the suspension was placed on ice for 20 min prior to spinning at 13,000 768 
RPM for 30 min at 4°C. The supernatant was removed and TRI Reagent (Sigma, 769 
T9424) was added to the histone–DNA-Pol II-RNA pellet. The TRI Reagent–pellet 770 
suspension was incubated at 65°C with intermittent vortexing to dissolve the pellet, 771 
and RNA was extracted following the manufacturer’s protocol. Poly(A) depletion was 772 
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performed with Dynabeads™ Oligo(dT)25 (ThermoFisher Scientific). The 773 
purification of nascent RNA was assessed by RT-PCR of CG12030, CG5059 and 774 
CG10802 genes which have slow rates of co-transcriptional splicing (Khodor et al., 775 
2011); cDNA synthesis was performed using qScript cDNA synthesis kit (Quanta 776 
Biosciences, 95047-025).  777 
RNA-seq 778 
Extracted RNA samples were quantified using a Nanodrop-8000 Spectrophotometer 779 
(ThermoFisher ND-8000-GL) to assess quality and to determine concentrations. 780 
Aliquots of each sample were diluted to ~5ng/µl, and tested with an Agilent 781 
Tapestation 2200 (Agilent G2964AA) using High Sensitivity RNA ScreenTapes kit 782 
(Agilent 5067- 5579) to determine the RNA Integrity Number.  783 
Total-RNA (1µg) was first poly(A) selected using the NEBNext® Poly(A) mRNA 784 
Magnetic Isolation Module (New England Biolabs E7490L) prior to library 785 
construction. Nascent RNA samples (100 ng) were processed without poly(A) 786 
selection. RNA libraries were prepared using a NEBNext Ultra Directional RNA 787 
Library Prep Kit (New England Biolab E7420L) and NEBnext Multiplex Oligos for 788 
Illumina Dual Index Primers (New England Biolabs E7600S), following standard 789 
protocols. RNA libraries were checked for quality using the Tapestation 2200 (Agilent 790 
G2964AA) with High Sensitivity D1000 DNA ScreenTape (Agilent 5067-5584). 791 
Multiplexed libraries were sequenced (50-bp single-end reads) on a HiSeq4000 792 
sequencer.  793 
CHIP-seq and RNA-seq data analysis 794 
ChIP-seq and RNA-seq data were initially viewed and analysed using the Lasergene 795 
Genomics Suite version 14 (DNASTAR). Pre-processing, assembly and mapping of 796 
the sequencing reads in the FASTQ files were performed by the SeqMan NGen 797 
software of this package automatically after selecting the NCBI D. melanogaster Dm6 798 
genome release and accompanying annotations. Assembly and alignment output files 799 
for each genome contig were then analysed with the ArrayStar and GenVision Pro 800 
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software (from the same package) to view and compare read profiles on the genome. 801 
Profiles at selected regions were saved as high-resolution images.  802 
To perform the metagene analyses, an index for Dm6 was downloaded from the 803 
HISAT2 website. HISAT2 v2.1.0 was then used to align the FASTQ files on it. The 804 
resulting SAM files were converted to BAM format, sorted, and indexed with 805 
Samtools 1.6. For the cytoplasmic RNA-seq data, the NCBI RefSeq gene annotations 806 
for Dm6 were downloaded as a refGene table from UCSC Table Browser 807 
(genome.ucsc.edu). The LiBiNorm tool was then used to produce read counts per gene 808 
in an HTSeq-count compatible format based on the refGene file (Dyer et al., 2019). 809 
Transcript lengths were also obtained from the refGene file and used together with 810 
total mapped sequencing reads to convert counts into RPKM values. For both 811 
ChIP-seq and nascent RNA-seq data, the BAM files were converted to Bedgraph files. 812 
This was carried out with the genomeCoverageBed command and options -bga and 813 
-ibam from the Bedtools v2.26.0 suite. Custom Perl scripts were then used to filter the 814 
Dm6 annotations either for genes separated by a minimum distance to avoid 815 
overlapping signals or RNA-seq expression levels. Subsequently, custom scripts were 816 
used to extract the signal from the Bedgraph files for each entry in the filtered gene 817 
list. A single base resolution was used for flanking regions, while the signal in gene 818 
bodies was binned into 16 bins to take account of different gene lengths. Each dataset 819 
was normalised by the total mapped sequencing reads in that dataset. 820 
Cross-referencing between different datasets was done based on the ‘name’ field, after 821 
filtering the annotations for multiple entries with the identical name.  822 
A custom script was used to extract the sequencing read coverage from the Bedgraph 823 
files for each exon/intron/exon region in the dm6 annotation file xon_fly_gene 824 
(downloaded from UCSC Table Browser). To normalise for any bias in the 825 
sequencing, the UPF1 signal of each exon or intron was divided by the average 826 
coverage in the input sample. The fold change of UPF1 signal/input signal in introns 827 
was compared to that of their flanking exons using Wilcox.test (two sided and 828 
unpaired) in R (www.r-project.org). This analysis was done using either all introns 829 
 32 
annotated in Dm6 (151623) or those longer than 100bp (76708). In either case 830 
flanking exons are significantly more enriched than introns. Here we have shown the 831 
result of analysis using just the longer introns as these were considered to be more 832 
informative because of the predicted lower resolution of ChIP at discriminating 833 
between closely adjacent sequences and because of the lower sequencing coverage of 834 
shorter introns compared to longer introns. All ChIP-seq and RNA-seq raw 835 
sequencing data and Bedgraph files were deposited in the GEO repository (Accession 836 
No GSE116808). All custom scripts used in this study are provided in Source Code 837 
File 1. 838 
 839 
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Figures legends 1055 
Figure 1.  UPF1 continuously shuttles between nucleus and cytoplasm.  1056 
(A) Western blotting of whole-cell lysate from either normal (lane 1) or transfected S2 1057 
cells expressing UPF1-GFP (lane 2), probed with the UPF1 monoclonal antibody 1058 
7B12. The proteins run according to their expected molecular weights: UPF1 (~130 1059 
kDa), and UPF1-GFP (~157 kDa) (B) Western blotting of S2 cells treated with dsRNA 1060 
targeting UPF1 or other RNA binding proteins indicated, used as controls. Different 1061 
sections of the membrane were probed with anti-UPF1 (7B12, top row), anti-eIF4AIII 1062 
(row 2), anti-Y14 (row 3) or anti-α-tubulin (row 4) as a loading control. (C) Western 1063 
blotting of UPF1 following nuclear (Nucl) and cytoplasmic (Cyto) fractionation of S2 1064 
cells. RNA Pol II and α-tubulin were detected using the corresponding antibodies on 1065 
the same blot (shown below). (D) Fluorescence immunolocalization of UPF1 (Cy3, 1066 
red) in 3rd instar larval salivary gland. The arrowheads in panel II and III (magnified 1067 
view of boxed area in panel I) point to the nucleolus, identified by no DAPI staining, 1068 
which, as other nucleoli, shows no UPF1 signal in its centre. (E) The plot shows 1069 
fluorescence loss in photobleaching (FLIP) of GFP-UPF1in salivary gland cells 1070 
photobleached in ROI1 (red circle, cytoplasm) and then GFP signal measured at the 1071 
identical time points in two separate ROI2s (red rings), in either cytoplasm or nucleus; 1072 
both equidistant from ROI1. The different lines show rate of GFP fluorescence loss in 1073 
either the photobleached ROI1 (blue line), or ROI2’ in the cytoplasm (red line) or 1074 
ROI2’’ in nucleus (purple line). Change in fluorescence intensity at equivalent regions 1075 
in neighbouring cells was measured as a control during the same time-course (black 1076 
line). Y-axis shows normalized relative fluorescence intensity while X-axis shows 1077 
time (seconds) from the start of imaging.  Quantification based on imaging 1078 
experiments in 8 different cells. (F) Plot shows fluorescence recovery after 1079 
photobleaching (FRAP) of GFP-UPF1 in either cytoplasm (ROI’, blue line) or nucleus 1080 
(ROI’’, red line) of salivary gland cells. Line values represent the average of 8 separate 1081 
measurements in different cells. Error bars in E and F indicate ± Standard Error. 1082 
1083 
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Figure 1-figure supplement 1. Generation of monoclonal antibodies against 1084 
Drosophila UPF1.  1085 
(A) Schematics of UPF1 showing its different structural domains. The peptides used 1086 
as immunogens and their respective amino acid locations are given in brackets 1087 
(sequences are in Supplementary file 1). The peptides indicated by red color produced 1088 
the monoclonal antibodies with highest specificity, as shown below (B) Western 1089 
blotting of S2 cell protein extracts, probed with 18 ascites induced with hybridomas 1090 
previously screened for their reactivity to the corresponding peptides (terminal 1091 
numbers correspond to different peptides indicated in A).  Lanes labelled M show a 1092 
molecular weight marker. (C) Western blotting of whole-cell lysate with the UPF1 1093 
monoclonal antibody (mab) 1C13, purified from hybridoma supernatants, from either 1094 
normal (lane 2) or transfected S2 cells expressing UPF1-GFP (lane 3) in which the two 1095 
bands correspond to either endogenous UPF1 or UPF1-GFP. (D) As in C, using mab 1096 
7D17. Western blotting with 7B12 is shown in Figure 1A. 1097 
1098 
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Figure 1-figure supplement 2. UPF1 immunostaining signals are reduced in 1099 
UPF1-RNAi salivary glands.   1100 
(A) Fluorescence immunolocalisation of UPF1 (Cy3, red) in 3rd instar larval salivary 1101 
gland, using three different antibodies: 7B12 (I to IV), 7D17 (V to VIII) or 1C13 (IX 1102 
to XII) in either wild-type (left panels) or FkhGAL4>UPF1RNAi (right panels). 1103 
Yellow arrows in III, VII and XI are indicating the fat body associated with 1104 
corresponding salivary glands. Nuclei were counter-stained with DAPI (blue). (B) 1105 
Colocalisation of transgenic GFP-UPF1 (green) and tetramethylrhodamine 1106 
conjugated Wheat Germ Agglutinin (WGA, red) in salivary gland cells. Lower panels 1107 
are magnified views of boxed area in upper panel. 1108 
1109 
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Figure 1-figure supplement 3. UPF1 subcellular localization in different larval 1110 
tissues.  1111 
(A) Fluorescence immunolocalisation of UPF1 (Cy3, red) in 3rd instar larval 1112 
Malpighian tubule (I to IV). Panel III shows magnified view of boxed area in panel I, 1113 
where white arrow indicates UPF1 signal within nucleus of a Principal Cell (PC). 1114 
Tissues were counter-stained with DAPI (blue). Line profiles (V) show both Cy3 and 1115 
DAPI fluorescence intensities along the yellow line drawn (IV). (B) 1116 
Immunolocalisation of UPF1 (Cy3, red) in gut cells (I to IV). Panel III shows 1117 
magnified view of boxed area in panel I. Arrow and arrowhead in (III) indicate 1118 
presence of UPF1 within nuclei of Enterocytes Cell (EC) and Adult Midgut Progenitor 1119 
Cells (AMPs) respectively. The line profiles show both Cy3 and DAPI fluorescence 1120 
intensities along the yellow line (IV) across both EC and AMPs cells (V). 1121 
1122 
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Figure 2. UPF1 shuttling between nucleus and cytoplasm requires its RNA 1123 
helicase activity.  1124 
(A) Imaging of 3rd instar larval salivary glands over-expressing GFP-UPF1 (green), 1125 
incubated for 1 hr in either normal M3 media (Control, I to IV) or supplemented with 1126 
50nM LMB (LMB, V to VIII). Panels II, IV, VI and VIII are magnified views of the 1127 
boxed areas in panel I, III, V and VII, respectively. The red arrows in II and VI 1128 
indicate the nucleoli. Nuclei were counter-stained with DAPI (blue). (B) Imaging of 1129 
transfected Drosophila S2 cells expressing either GFP-UPF1 (I to IV), UPF1-GFP (V 1130 
to VIII), GFP-UPF1(DE-AA) (IX to XII) or UPF1(DE-AA)-GFP (XIII to XVI), 1131 
incubated for 1 hr with or without 50nM LMB (right vs. left panels). The magenta 1132 
coloured arrows indicate the nuclei, which were counter-stained with DAPI (blue) in 1133 
the even numbered panels. 1134 
 1135 
1136 
 45 
Figure 2-figure supplement 1. UPF1 is highly dynamic within both nucleus and 1137 
cytoplasm.  1138 
(A) Time-lapse live cell imaging showing changes in the cellular distribution of 1139 
GFP-UPF1 in 3rd instar larval salivary gland at different time intervals of LMB 1140 
treatment. Start* refers to the first image acquired straight after dissection and 1141 
mounting of the tissues in a cavity slide, the procedure takes ~5-6 minutes during 1142 
which time the cells have been exposed to LMB. (B) Localisation of GFP-UPF1 1143 
(green) in salivary glands either after 1 hr heat shock (I to IV) or after a further 1 hr 1144 
recovery following heat shock (V to VIII). Lower panels are magnified views of 1145 
boxed area in upper panel, with or without DAPI counter-staining (blue). 1146 
1147 
 46 
Figure 3.  UPF1 binds at transcriptionally active sites on the polytene 1148 
chromosomes.  1149 
(A) Fluorescence immunolocalization of UPF1 (Cy3, red, I) on polytene 1150 
chromosomes (DAPI, blue, II). Chromosome arms (X, 2L, 2R, 3L and 3R) and 1151 
chromocentre (CC) are labelled. The labels indicate cytological locations of interband 1152 
regions at the X chromosome, presenting apparent UPF1 signal. The line profile (III, 1153 
white panel) shows signal intensities along the white line drawn on the X 1154 
chromosome, UPF1 (red) and DAPI (blue). (B) Immunolocalization of UPF1 (red) on 1155 
polytene chromosomes derived from larvae subjected to a 40 min heat shock at 370C. 1156 
UPF1 signals are primarily detected at heat shock gene loci, indicated by their 1157 
cytological locations (yellow arrowheads), using their standard nomenclature. (C) 1158 
Immunolocalization of UPF1 (red) at an ecdysone induced transgene (named S136) 1159 
located at cytological position 63B (yellow line) and the same region on the wild type 1160 
chromosome after ecdysone treatment. The white dotted lines indicate flanking bands 1161 
as mapping reference. Chromosomes were stained with DAPI (grey in middle panel or 1162 
blue in bottom panel). 1163 
1164 
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Figure 3-figure supplement 1. RNAi fully depletes UPF1 signal at the salivary 1165 
gland polytene chromosomes. 1166 
 (A) Fluorescence immunolocalisation of UPF1 using the 7B12 monoclonal antibody 1167 
(Cy3, red) on polytene chromosomes (blue) of wild type (I, II) and 1168 
FkhGAL4>UPF1-RNAi (III, IV) salivary glands. (B) Western blotting probed with 1169 
7B12 mab for protein extracts of 3rd instar larval salivary gland from 1170 
FkhGAL4>GFP-UPF1 (lane I), wild type (lane II) and FkhGAL4>UPF1-RNAi (lane 1171 
III). Ponceau staining of the same blot showing equal protein loading. (C) 1172 
Fluorescence immunolocalisation of UPF1 using the two other antibodies described: 1173 
7D17 (I, II) or 1C13 (III, IV) (Cy3, red). No signal is detected on polytene 1174 
chromosomes in the absence of primary antibody (V, VI). (D) Immunolocalisation of 1175 
GFP-UPF1 (FITC, green, I and II) on polytene chromosomes of 1176 
FkhGAL4>GFP-UPF1 salivary glands, detected using anti-GFP antibody. 1177 
Chromosomes were counter stained with DAPI (blue, II). Line profiles in III show 1178 
both signal intensities along the white line traced on the chromosome arm in II. Note 1179 
that the UPF1 signal peaks at chromatin-decondensed regions characterised by low 1180 
DAPI signal.  1181 
 1182 
1183 
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Figure 3-figure supplement 2. UPF1 chromosomal association is transcription 1184 
and nascent RNA dependent.  1185 
(A) Co-immunolocalisation of UPF1 (FITC, green, I, III) and Ser2 Pol II (Cy3, red, II, 1186 
III) on polytene chromosomes, counterstained with DAPI (blue). Line profiles in IV 1187 
show all signal intensities along the white line drawn in III. (B) Immunolocalisation of 1188 
UPF1 (red, I and II) and hnRNPA1 (red, III and IV) at polytene chromosomes of either 1189 
untreated salivary glands (I and III) or treated with RNase (II and IV). (C) Graph 1190 
shows normalised fluorescence intensity of the hnRNPA1 and UPF1 signals in control 1191 
and after RNase treatment, based on mean intensities of 8-10 different nuclear 1192 
spreads. (D) Immunolocalisation of UPF1 (red, I and II) and Ser2 Pol II (red, III and 1193 
IV) at polytene chromosomes from either untreated salivary glands (I and III) or DRB 1194 
treated (II and IV). (E) Graph shows normalised fluorescence intensity of Ser2 Pol II 1195 
and UPF1 in control and after DRB treatment of 8 different chromosomes spreads, 1196 
based on mean intensities of the signal on all chromosome arms. Error bars in C and E 1197 
indicate ± Standard Error. 1198 
1199 
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Figure 4. UPF1 associates at Pol II transcription sites.  1200 
(A) Genome browser visualization of UPF1 (red) and Ser2 Pol II (pink) ChIP-seq 1201 
enrichment profiles at a representative chromosomal region in S2 cells, including 1202 
highly active genes (green) and low or inactive genes (orange).  The input profile 1203 
(grey) is shown in the bottom panel on the same scale as that of UPF1 (B) Scatter plot 1204 
showing correlation between normalised exon reads in UPF1 and Ser2 Pol II ChIP-seq 1205 
samples. (C) Scatter plot showing relationship between normalised UPF1 ChIP-reads 1206 
vs. mRNA-seq expression levels; data points corresponding to either exons (blue) or 1207 
introns (red). Correlation values are 0.485 and 0.398, for exons (blue line) and introns 1208 
(red line) respectively. (D) Metagene profiles showing average UPF1 occupancy at 1209 
either active (blue, RPKM >1) or inactive/low expressed transcription units (RPKM 1210 
<1, orange), gene body (scaled to 16 bins of gene full length) plus 500 bp from either 1211 
end. The number of individual transcription units (N) used for this analysis is given on 1212 
top. Corresponding normalised input profiles are shown by dotted lines. (E) 1213 
Superimposed metagene plots of UPF1 (red) and Ser2 Pol II (pink) at highly 1214 
expressed gene loci (RPKM >5). The input enrichment profile for same gene set is 1215 
shown by the dotted line (black). (F) Graph shows ChIP-seq enrichment profiles of 1216 
UPF1 (red) and Ser2 Pol II (pink) at the RpL23A gene. Bottom panel shows real-time 1217 
PCR quantification of Ser2 Pol II (left) and UPF1 (right) average enrichment at 1218 
RpL23A gene, based on two separate ChIP replicates from either normal or DRB 1219 
treated S2 cells. The relative position of the three amplicons tested (Start, Middle and 1220 
End of the gene) are indicated by black boxes underneath the gene schematic on top. 1221 
Error bars indicate ± Standard Error. 1222 
1223 
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Figure 4-figure supplement 1.  Real-time PCR validation of UPF1 ChIP 1224 
association at selected genes.  1225 
(A) UPF1 (red) and Ser2 Pol II (pink) ChIP-seq enrichment profiles at RpL23A (on 1226 
left) and RpS12 (on right) gene loci. (B) Real-time PCR quantification of average 1227 
ChIP signal of either endogenous UPF1 (red) or GFP (as negative control, grey) at the 1228 
RpL23 and RpS12 genes in salivary glands expressing GFP. The locations of the 1229 
primer pairs used are indicated by the black boxes (P) shown below the genes 1230 
schematics in A. (C) Real-time PCR quantification of average UPF1 association in 1231 
control (red) or UPF1-RNAi (blue) S2 cells. (D) Real-time PCR quantification of 1232 
average UPF1 association at three distinct regions of RpL23 in S2 cells (same primers 1233 
pairs as in Figure 4F), with (blue) or without (red) RNase A treatment. (E) Ser2 Pol II 1234 
immunoprecipitation of S2 cell nuclear extracts using anti-Ser2 Pol II antibody 1235 
(ab5095) and detection (same blot) of Ser2 Pol II, UPF1, eIF4AIII and hnRNPA1, in 1236 
control (lanes 2-3) or RNase treated samples (lanes 4-5). IP refers to 1237 
immunoprecipitated fractions, Ub to unbound fractions. Error bars in B, C and D 1238 
indicate ± Standard Error. 1239 
1240 
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Figure 4-figure supplement 2. ChIP-seq profiles of UPF1 at representative Pol II 1241 
genes and some Pol III loci.  1242 
(A) ChIP-seq profiles of UPF1 (red) and Ser2 Pol II (pink) at different active genes 1243 
characterised by either paused or not paused Pol II at the TSS (panels 1-3). Panels 4 1244 
and 5 show absence of Upf1 at two inactive genes, with or without paused Pol II. (B) 1245 
ChIP-seq profile of UPF1 (red) and Ser2 Pol II (pink) at the three Pol III transcribing 1246 
gene loci indicated. (C) ChIP-seq profiles showing no UPF1 signal at three highly 1247 
transcribing Pol III genes (snRNPU6, 5SrRNA and tRNA:Arg). 1248 
1249 
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Figure 5. Intron recognition interferes with UPF1 association on nascent 1250 
transcripts.  1251 
(A) Schematic of the Xrp1 locus (top) showing its two main transcription units. 1252 
Below, UPF1 (red) and Ser2 Pol II (pink) ChIP-seq profiles at this gene; that of the 1253 
input is shown below (grey). The bottom two panels show nascent RNA-seq (blue) 1254 
and poly(A) RNA-seq (purple) profiles. (B) Real-time PCR quantification of average 1255 
enrichment in different regions in either exons (E1, E3, E4 and E6) or introns (I3 or I4) 1256 
in multiple UPF1 ChIP replicates. Error bars indicate ± Standard Error. (C) Box plots 1257 
of normalised UPF1 ChIP-seq reads mapping at either left exon (shown on left), intron 1258 
(middle) or right exon (on right). Whiskers correspond to +/- 1.5 interquartile range 1259 
with respect to quartiles. Wilcoxon rank sum test values are: left exon vs. intron, 1260 
p-value = 6.737e-08; right exon vs intron, p-value = 2.391e-09; and, left exon vs. right 1261 
exon p-value = 0.606. *** p < 0.001 for difference in UPF1 signal between intron and 1262 
its flanking exon. (D) Line profile of average UPF1 ChIP-seq/input enrichment 1263 
expressed as percentage of full length in either exons or intron. Analysis is based on 1264 
151623 introns of any length (orange line) or 76708 introns longer than 100 bp (red 1265 
line) as annotated in the dm6 genome release. 1266 
1267 
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Figure 5-figure supplement 1.  Additional examples of UPF1 ChIP-seq profiles at 1268 
genes with or without introns.  1269 
(A) ChIP-seq profiles showing enrichment of UPF1 (red) and Ser2 Pol II (pink) at 1270 
genes without intron. Blue arrows indicate their coding sequences (CDS). (B) 1271 
ChIP-seq profile showing enrichment of UPF1 (red) and Ser2 Pol II (pink) at other 1272 
highly expressing intron-containing genes. Dotted lines demarcate regions around 1273 
intron/exon borders at which UPF1 shows higher association with exons despite 1274 
uniform Ser2 distribution. The blue arrow in Actin5C diagram indicates its CDS. (C) 1275 
UPF1 ChIP-seq profile (red) and Ser2 Pol II (pink) at CG5059 gene, which, as 1276 
indicated by the nascent RNA-seq profile underneath (blue), show high intronic 1277 
sequencing reads, indicative of inefficient co-transcriptional splicing. 1278 
1279 
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Figure 5-figure supplement 2. UPF1 association with nascent transcripts might 1280 
depend on 5’ splice sites recognition. 1281 
 (A) Density plots of UPF1 enrichment at either the exon before (red line), exon after 1282 
(orange line) or the intron (blue line). The x-axis shows the log2 of the normalized (by 1283 
input) UPF1 ChIP signal; the right half of the graph shows the density of the values 1284 
that are enriched, the left half (shadowed) those that are not. (B) Proposed models of 1285 
how UPF1 scanning of the nascent transcript is connected to intron recognition during 1286 
spliceosome assembly: Model 1 (top) predicts that splicing enhances binding of UPF1 1287 
to downstream exons, Model 2 (bottom) that intron recognition blocks UPF1 1288 
association with introns. Spliceosomal snRNPs (U1, U2/U6 and U5) are represented 1289 
by orange oval shapes, the squiggle drawing within U1 snRNP signifies the base 1290 
pairing between U1 snRNA and the 5’ ss; TSS indicate the transcription start site; and 1291 
TES, the transcription end site. Exons are indicated by either thin blue lines (5’ UTRs) 1292 
or rectangles (coding regions). (C) Real-time PCR quantification of UPF1 ChIP 1293 
enrichment (two replicates) at intron (I4) or exon (E6) of the Xrp1 gene, in either 1294 
normal S2 cells or cells RNAi depleted of the proteins indicated. Error bars indicate ± 1295 
Standard Error. 1296 
1297 
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Figure 6. UPF1 knockdown results in nuclear accumulation and transcription 1298 
sites retention of poly(A) mRNA.  1299 
(A) Fluorescence in situ hybridization (FISH) with a rhodamine-labelled oligo(dT)45 1300 
probe of 3rd instar larval salivary glands, from either wild-type (top panel), 1301 
UPF1-RNAi (middle panel) or UPF1-RNAi glands expressing human UPF1 (hUPF1, 1302 
bottom panel). Chromosomes were counterstained with DAPI (blue). White arrow and 1303 
yellow arrow indicate interchromosomal and perinucleolar aggregates respectively. 1304 
(B) Oligo(dT)45 FISH (as above) of 3rd instar larval salivary gland polytene 1305 
chromosomes from either wild type or UPF1-RNAi. Chromosomes were 1306 
counterstained with DAPI (blue). (C) Proposed model of accumulation of newly 1307 
transcribed poly(A) mRNA at the site of transcription in UPF1 depleted cells (right) 1308 
compared with wild type (left). Abbreviations: NPC for nuclear pore complex and 1309 
CPC for cleavage and polyadenylation complex. 1310 
 1311 
1312 
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Supplementary file 1. Peptides used for UPF1 antibody generation 1313 
 1314 
Supplementary file 2. Most enriched transcription units by UPF1 ChIP-seq  1315 
 1316 
Supplementary file 3. List of PCR primers used 1317 
 1318 
Source code file 1. Custom scripts used to analyse ChIP-seq and RNA-seq data  1319 
 1320 
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